Novozymes and Prometic enter into alliance for purification of albumin-fusion proteins

04-Feb-2010 - Denmark

Novozymes and ProMetic Life Sciences Inc. announced that they have entered into a strategic alliance regarding proprietary albumin purification technology based upon a synthetic-ligand affinity adsorbent developed by ProMetic’s UK subsidiary, ProMetic BioSciences Ltd. The purification technology has been designed for the rapid and cost-effective development of Novozymes’ albufuse® albumin-fusion molecules.

Under the terms of the co-marketing alliance the companies will jointly promote the use of a new synthetic-ligand affinity adsorbent, marketed under the trade-name AlbuPure®, as a platform approach for the purification of albumin and albumin-fusion proteins. ProMetic will be the exclusive manufacturer and supplier of AlbuPure®, however both parties will retain ownership of their respective technologies and both Novozymes and ProMetic will have the right to market AlbuPure®.

Other news from the department business & finance

Most read news

More news from our other portals

So close that even
molecules turn red...